Today: 9 June 2026
Broadcom stock price: AVGO ends lower as Nvidia earnings loom and AI spending debate heats up
22 February 2026
2 mins read

Broadcom stock price: AVGO ends lower as Nvidia earnings loom and AI spending debate heats up

NEW YORK, February 22, 2026, 11:16 EST — Market closed

  • Broadcom ended Friday off 0.4%, trailing gains in the wider U.S. market.
  • Monday’s session opens with traders looking for any signals from Nvidia’s results, set to drop midweek.
  • AI infrastructure spending is grabbing headlines again, with Broadcom’s March earnings call on deck.

Broadcom Inc. closed out Friday at $332.65, slipping 0.4%. The stock moved between $329.58 and $340.11 throughout the session. Yahoo Finance data put volume at roughly 17.6 million shares.

U.S. markets are closed for the weekend, but all eyes are already on the next trading session and the week ahead. The spotlight is on Nvidia’s quarterly results, landing Feb. 25, a report that could set the tone for chip stocks. Broadcom (AVGO) tends to get swept up with the usual AI hardware crowd as traders calibrate bets around headline earnings numbers.

Nvidia remains the go-to name for investors trying to gauge if the data-center spending boom is still fueling solid gains throughout the AI supply chain. “It’s hard for Nvidia to surprise when everyone expects it to surprise,” said Marta Norton, chief investment strategist at Empower, in a Reuters Week Ahead report. Reuters

Broadcom fell 0.40% Friday, according to MarketWatch data, while the S&P 500 advanced 0.69% and the Dow rose 0.47%. Semiconductor stocks posted mixed moves, with Broadcom lagging as the broader U.S. indexes climbed.

Nvidia climbed 1.0% to $189.82. Over at Marvell Technology, shares slipped 0.2% to $79.48. Arista Networks, the networking hardware player, dropped 3.2% to $132.79, highlighting just how mixed trading was among AI infrastructure stocks.

Broadcom is lining up a key event: it plans to release first-quarter fiscal 2026 numbers on March 4 after the market closes, with a conference call scheduled for 2:00 p.m. Pacific (5:00 p.m. Eastern).

AI’s influence is hardly a fresh story, but the edges keep sharpening. Last year, OpenAI inked an agreement with Broadcom to craft its first in-house AI chip, and according to Reuters, rollout should kick off in the back half of 2026. “Partnering with Broadcom is a critical step in building the infrastructure needed to unlock AI’s potential,” OpenAI CEO Sam Altman said at the time. Reuters

The capex debate isn’t fading anytime soon. OpenAI is eyeing about $600 billion in total compute spend by 2030, a person familiar told Reuters on Friday, as the company positions itself for a potential IPO.

Nvidia is nearing completion of a $30 billion investment in OpenAI, according to a person with knowledge of the talks, as the AI firm pushes ahead with its fundraising. The move underscores the tightening bond between chipmakers, cloud services, and AI model developers.

The flip side is hard to ignore. Broadcom shares took a steep dive in December when the company flagged pressure on margins from booming sales of custom AI chips that come with thinner profits—a clear signal that not every AI-driven sales surge translates directly into net income.

All eyes turn next to Nvidia’s earnings and call on Feb. 25. After that, Broadcom steps up on March 4. Investors want specifics: how AI demand is shaping up, what’s happening with custom chip rollouts, and any new margin talk.

Stock Market Today

  • Soybean Prices Decline Amid Lower Export Shipments and Reduced Speculative Positions
    June 9, 2026, 9:21 AM EDT. Soybean prices fell between 2 and 5 ½ cents on Monday, with the national average cash price dropping to $10.58 3/4 per bushel. Export shipments for the week ending June 4 decreased by 21.2% from the previous week, totaling 398,186 MT, and are down 28.8% year-over-year. Key buyers included Egypt, China, and Mexico. Marketing year exports stand 20.3% lower compared to last year. Meanwhile, speculative traders reduced their net long positions in soybean futures and options by 33,502 contracts, signaling cautious market sentiment. Soymeal and soy oil futures also declined modestly. A private export sale of 264,000 MT was reported for the 2026/27 season, but overall market pressure weighs on prices going into the week.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results
Previous Story

Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results

Robinhood stock: what to know before Monday after Goldman trims target, filing tweaks annual report
Next Story

Robinhood stock: what to know before Monday after Goldman trims target, filing tweaks annual report

Go toTop